Meningococcal B vaccine
At present there are around 200 cases of meningococcal disease each year in Australia. The highest incidence are those under 5 years (about 50 – 60 cases per year) and those under 12 months have a higher incidence of death.
The Meningococcal B vaccine – Bexsero is for anyone at risk but inparticularly:
infants from 2 months and young children, particularly under 24 months
Adolescents aged 15 to 19
Children and adults with conditions that place them at a high risk, such as problems with immunity or an absent spleen
The bexsero vaccine helps protect children against Meningococcal disease which is a rare but serious infection of the blood and /or brain.
Please discuss this option with your doctor or the nurse at your next visit.
We also stock a variety of the most common travel vaccinations including Twinrix (Hep A & B), Typhoid, Adacel (Tetanus & Whooping cough) and Vivaxim (Hep A & Typhoid).
They can be administerd at the time of your travel consultation.
Please call 07 3207 8222